HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

T Kawabata Selected Research

Lipopolysaccharides

3/2007Mice deficient in Vbeta8+NKT cells are resistant to experimental hepatitis but are partially susceptible to generalised Shwartzman reaction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


T Kawabata Research Topics

Disease

3Systemic Lupus Erythematosus (Libman-Sacks Disease)
11/2018 - 01/2016
3Neoplasms (Cancer)
10/2001 - 01/2000
2Autism Spectrum Disorder
01/2017 - 01/2017
2Schizophrenia (Dementia Praecox)
01/2017 - 01/2017
2Renal Cell Carcinoma (Grawitz Tumor)
04/2001 - 01/2000
1Neuromyelitis Optica (Devic's Disease)
07/2018
1Neurodevelopmental Disorders
01/2017
1Mental Disorders (Mental Disorder)
01/2017
1Fatigue
01/2016
1Thymoma (Thymic Carcinoma)
09/2014
1Psoriasis (Pustulosis Palmaris et Plantaris)
11/2013
1Hypersensitivity (Allergy)
01/2012
1Wounds and Injuries (Trauma)
12/2010
1Crohn Disease (Crohn's Disease)
05/2009
1Hepatitis
03/2007
1Necrosis
03/2007
1Shwartzman Phenomenon (Shwartzman Reaction)
03/2007
1Thrombosis (Thrombus)
08/2005
1Listeriosis (Listeria Infection)
04/2005
1Infections
04/2005
1Tuberculosis (Tuberculoses)
10/2001
1Graft vs Host Disease (Graft-Versus-Host Disease)
10/2001
1Carcinoma (Carcinomatosis)
10/2001
1Carcinogenesis
04/2001
1Chest Pain (Chest Pains)
12/2000
1Neoplasm Metastasis (Metastasis)
01/2000

Drug/Important Bio-Agent (IBA)

2Interleukin-18 (Interleukin 18)IBA
04/2005 - 10/2001
1Complement System Proteins (Complement)IBA
11/2018
1Rituximab (Mabthera)FDA Link
07/2018
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
01/2017
1NucleotidesIBA
01/2017
1Nogo Receptor 1IBA
01/2017
1rho-Associated KinasesIBA
01/2017
1Tacrolimus (Prograf)FDA LinkGeneric
01/2016
1Vincristine (Oncovin)FDA LinkGeneric
09/2014
1Doxorubicin (Adriamycin)FDA LinkGeneric
09/2014
1Etoposide (VP 16)FDA LinkGeneric
09/2014
1Cisplatin (Platino)FDA LinkGeneric
09/2014
1tofacitinibIBA
11/2013
1Janus KinasesIBA
11/2013
1Janus Kinase InhibitorsIBA
11/2013
1Anti-Bacterial Agents (Antibiotics)IBA
01/2012
1Anticonvulsants (Antiepileptic Drugs)IBA
01/2012
1Cell Adhesion MoleculesIBA
05/2009
1LipopolysaccharidesIBA
03/2007
1alpha-galactosylceramideIBA
03/2007
1Concanavalin AIBA
03/2007
1InterferonsIBA
03/2007
1InterleukinsIBA
03/2007
1Interleukin-4 (Interleukin 4)IBA
03/2007
1CytokinesIBA
03/2007
1FibrinIBA
08/2005
1Interleukin-12 (IL 12)IBA
04/2005
1AgarIBA
04/2001
1ferric nitrilotriacetateIBA
04/2001
1Nitroglycerin (Dynamite)FDA LinkGeneric
12/2000

Therapy/Procedure

1Drug Therapy (Chemotherapy)
09/2014
1Induction Chemotherapy
09/2014
1Maggot Debridement Therapy
12/2010
1Injections
03/2007
1Therapeutics
08/2005
1Splenectomy
04/2005
1Nephrectomy
01/2000
1Palliative Care (Palliative Therapy)
01/2000
1Minimally Invasive Surgical Procedures
01/2000